Aims: Total knee arthroplasty is a common procedure for patients with advanced gonarthrosis, often leading to significant postoperative pain. Effective pain management, including multimodal analgesia with peripheral nerve blocks, is essential. The suprainguinal fascia iliaca block is a technique that targets key nerves responsible for knee sensation and is similar in effect to the lumbar plexus block. This research aims to evaluate whether suprainguinal fascia iliaca block improves the Quality of Recovery-15 scores in Total knee arthroplasty patients.
Methods: A randomized, prospective, controlled, multicenter study was conducted with 60 patients undergoing total knee arthroplasty. Participants were allocated to either Group S (received SIFIB with local anesthetic) or Group C (received SIFIB with saline solution). The primary outcome measured was the Quality of Recovery-15 score 24 hours post-surgery. Secondary outcomes included postoperative numeric rating scale scores, the requirement for rescue analgesia, time to first rescue analgesia, postoperative complications (nausea and vomiting), the necessity for antiemetics, and patient satisfaction.
Results: Group S had significantly higher QoR-15 scores (124 [121–129] vs. 98 [92–101]; p<0.001) and lower numerical rating scale scores at all time points compared with Group C (p<0.001). The total amount of tramadol consumed within the first 24 hours postoperatively was higher in Group C (145 [80–225] mg vs. 0 [0–0] mg; p<0.001).
Conclusion: Suprainguinal fascia iliaca block significantly enhances postoperative recovery and pain management in total knee arthroplasty patients, presenting a viable alternative to other regional blocks for knee surgery.
Multimodal analgesia postoperative recovery quality of recovery-15 score Suprainguinal fascia iliaca block
Amaç: Total diz artroplastisi, ileri gonartrozlu hastalar için yaygın bir cerrahi prosedürdür ve genellikle önemli ölçüde postoperatif ağrıya yol açar. Etkili ağrı yönetimi, çevresel sinir blokları ile multimodal analjeziyi içerir ve bu süreçte hayati öneme sahiptir. Suprainguinal fascia iliaka bloğu, dizin duyusundan sorumlu temel sinirleri hedef alan ve lumbar pleksus bloğuna benzer etkiler gösteren bir tekniktir. Bu araştırma, suprainguinal fascia iliaka bloğunun total diz artroplastisi hastalarında Quality of Recovery-15 skorlarını iyileştirip iyileştirmediğini değerlendirmeyi amaçlamaktadır.
Yöntem: Total diz artroplastisi geçiren 60 hasta ile randomize, prospektif, kontrollü ve çok merkezli bir çalışma yürütülmüştür. Katılımcılar, Grup S (lokal anestezik ile SIFIB uygulanan grup) veya Grup C (salin solüsyonu ile SIFIB uygulanan grup) olmak üzere iki gruba ayrılmıştır. Birincil sonuç ölçütü, ameliyat sonrası 24. saatte Quality of Recovery-15 skoruydu. İkincil sonuçlar arasında postoperatif sayısal derecelendirme ölçeği skorları, kurtarma analjezisine olan ihtiyaç, ilk kurtarma analjezisinin zamanı, postoperatif komplikasyonlar (bulantı ve kusma), antiemetik gereksinimi ve hasta memnuniyeti yer almıştır.
Bulgular: Grup S’nin QoR-15 skorları, Grup C’ye kıyasla anlamlı derecede daha yüksekti (124 [121–129] vs. 98 [92–101]; p<0.001). Ayrıca, tüm zaman noktalarında Grup S'nin sayısal derecelendirme ölçeği skorları Grup C’ye kıyasla daha düşüktü (p<0.001). İlk 24 saat içinde tüketilen toplam tramadol miktarı Grup C’de daha yüksekti (145 [80–225] mg vs. 0 [0–0] mg; p<0.001).
Sonuç: Suprainguinal fascia iliaka bloğu, total diz artroplastisi hastalarında postoperatif iyileşmeyi ve ağrı yönetimini önemli ölçüde iyileştirerek, diz cerrahisinde diğer bölgesel bloklara uygulanabilir bir alternatif sunmaktadır.
Multimodal analjezi postoperatif iyileşme iyileşme kalitesi-15 skoru Suprainguinal fasya iliaka bloğu
| Primary Language | English |
|---|---|
| Subjects | Anaesthesiology |
| Journal Section | Original Article |
| Authors | |
| Publication Date | January 12, 2025 |
| Submission Date | December 3, 2024 |
| Acceptance Date | December 21, 2024 |
| Published in Issue | Year 2025 Volume: 8 Issue: 1 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
| ||
|
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.